(4) including ion channels (5-7) and enzymes such as CaM-dependent protein kinase II (CaMKII) (8), myosin light chain kinase (MLCK) (9), nitricoxide synthase (10), and CaM-dependent phosphatase calcineurin (CaN) (11), which play central roles in diverse cellular processes. For example, CaMKII is implicated in regulation of the excitation-contraction coupling (8, 12) and apoptosis in the heart (13, 14), whereas CaN dephosphorylates transcription factors to regulate gene expression related to cardiac hypertrophy and heart failure (11). Despite the wide appreciation of the importance of Ca, CaM, and CaM targets on cardiac myocyte function, an intriguing question remains unsolved about how CaM and its target proteins differentiate Ca 2ϩ signals to ensure the appropriate cellular responses in the heart.The concentration of free CaM in adult ventricular myocytes is ϳ50 -100 nM, which is only 1-2% of the total myocyte CaM (15). Thus, the pool of free CaM is limited given the abundance of CaM targets in muscle cells (16). As a result, there is likely intense competition among CaM targets for CaM activation in response to Ca 2ϩ signals in cardiomyocytes. Consequently, the action of different CaM targets in processing Ca 2ϩ signals may be at least partially determined by their respective affinities for Ca 2ϩ -CaM. There is an extensive range of affinities for Ca 2ϩ -CaM among CaM targets (K d values vary from ϳ0.1 to Ͼ100 nM) (4). For instance, CaN has a particularly high affinity (K d ϭ ϳ0.1 nM) (17) for Ca 2ϩ -CaM, whereas the affinity of CaMKII for Ca 2ϩ -CaM is much lower (K d ϭ ϳ50 nM) (18). It has been shown that CaN responds to sustained, low amplitude Ca 2ϩ signals in lymphocytes and transduces these signals into the activation of nuclear transcriptional factor NFAT (19). In skeletal muscle, activation of CaN caused by sustained Ca 2ϩ signals (evoked by motoneuron stimulation) and subsequent nuclear translocation of NFAT has been suggested to modulate fiber type-specific gene expression (20). On the other hand, CaMKII * This work was supported, in whole or in part, by National Institutes of Health Grant HL30077 and HL80101 (to D. M. B.). This work was also supported by a postdoctoral fellowship from the American Heart Association (to Q. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.